Estimating Vaccine Efficacy Over Time After a Randomized Study is Unblinded (Q106191): Difference between revisions
From MaRDI portal
Added link to MaRDI item. |
Changed an Item |
||||||||||||||
Property / publication date | |||||||||||||||
30 October 2023
| |||||||||||||||
Property / publication date: 30 October 2023 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / author | |||||||||||||||
Property / author: Anastasios A. Tsiatis / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / author | |||||||||||||||
Property / author: Marie Davidian / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / DOI | |||||||||||||||
Property / DOI: 10.1111/biom.13509 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / title | |||||||||||||||
Estimating vaccine efficacy over time after a randomized study is unblinded (English) | |||||||||||||||
Property / title: Estimating vaccine efficacy over time after a randomized study is unblinded (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / zbMATH Open document ID | |||||||||||||||
Property / zbMATH Open document ID: 1520.62346 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / published in | |||||||||||||||
Property / published in: Biometrics / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / full work available at URL | |||||||||||||||
Property / full work available at URL: https://arxiv.org/abs/2102.13103 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / Mathematics Subject Classification ID | |||||||||||||||
Property / Mathematics Subject Classification ID: 62P10 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / zbMATH DE Number | |||||||||||||||
Property / zbMATH DE Number: 7756374 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / zbMATH Keywords | |||||||||||||||
crossover | |||||||||||||||
Property / zbMATH Keywords: crossover / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / zbMATH Keywords | |||||||||||||||
inverse probability weighting | |||||||||||||||
Property / zbMATH Keywords: inverse probability weighting / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / zbMATH Keywords | |||||||||||||||
potential outcomes | |||||||||||||||
Property / zbMATH Keywords: potential outcomes / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / zbMATH Keywords | |||||||||||||||
randomized phase 3 vaccine trial | |||||||||||||||
Property / zbMATH Keywords: randomized phase 3 vaccine trial / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / zbMATH Keywords | |||||||||||||||
waning vaccine efficacy | |||||||||||||||
Property / zbMATH Keywords: waning vaccine efficacy / rank | |||||||||||||||
Normal rank |
Latest revision as of 22:20, 26 April 2024
scientific article from arXiv
Language | Label | Description | Also known as |
---|---|---|---|
English | Estimating Vaccine Efficacy Over Time After a Randomized Study is Unblinded |
scientific article from arXiv |
Statements
24 February 2021
0 references
30 October 2023
0 references
stat.AP
0 references
stat.ME
0 references
Estimating vaccine efficacy over time after a randomized study is unblinded (English)
0 references
crossover
0 references
inverse probability weighting
0 references
potential outcomes
0 references
randomized phase 3 vaccine trial
0 references
waning vaccine efficacy
0 references